Xuebing Li

中国科学家在线 ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

Chemistry (Weinheim an der Bergstrasse, Germany)

Nature communications

RSC advances

Institute of Microbiology Chinese Academy of Sciences

Tottori University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Microbiology Chinese Academy of Sciences

China

Professor (Principal Investigator)

Hokkaido University

Japan

Research Fellow

National Institute of Agrobiological Science

Japan

Postdoctoral Fellow

Education History

Tottori University

Japan

PHD

Shandong Institute of Building Materials

China

BSC

Publications

Shuihong Cheng, Mingli Li, Yong Feng, Tong Liu, Lin He, Mingyue Xu, Liying Ma, Xuebing Li
Glycan-Modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells. Journal of medicinal chemistry (2024)
Shuihong Cheng, Mingli Li, Yong Feng, Tong Liu, Lin He, Mingyue Xu, Liying Ma, Xuebing Li
Glycan-Modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells. Journal of medicinal chemistry 67 (5) (2024)
Shuihong Cheng, Mingli Li, Yong Feng, Tong Liu, Lin He, Mingyue Xu, Liying Ma, Xuebing Li
Glycan-Modified Peptides for Dual Inhibition of Human Immunodeficiency Virus Entry into Dendritic Cells and T Cells. Journal of medicinal chemistry 67 (5) (2024)
Pengfei Wang, Babayemi Olawale Oladejo, Chenning Li, Lifeng Fu, Shanshan Zhang, Jianxun Qi, Xun Lv, Xuebing Li
Structure-based design of 5'-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors. RSC advances 11 (16) (2021)
Xun Lv, Pengfei Wang, Chenning Li, Shuihong Cheng, Yuhai Bi, Xuebing Li
Zanamivir-Cholesterol Conjugate: A Long-Acting Neuraminidase Inhibitor with Potent Efficacy against Drug-Resistant Influenza Viruses. Journal of medicinal chemistry 64 (23) (2021)
Lifeng Fu, Fei Ye, Yong Feng, Feng Yu, Qisheng Wang, Yan Wu, Cheng Zhao, Huan Sun, Baoying Huang, Peihua Niu, Hao Song, Yi Shi, Xuebing Li, Wenjie Tan, Jianxun Qi, George Fu Gao
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nature communications 11 (1) (2020)
Xun Lv, Hongzhi Cao, Baixue Lin, Wei Wang, Wande Zhang, Qian Duan, Yong Tao, Xue-Wei Liu, Xuebing Li
Synthesis of Sialic Acids, Their Derivatives, and Analogs by Using a Whole-Cell Catalyst. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (60) (2017)

Xuebing Li.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xuebing Li